Fetzima (Allergan USA, Inc.)
Welcome to the PulseAid listing for the Fetzima drug offered from Allergan USA, Inc.. This Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Allergan USA, Inc. |
NON-PROPRIETARY NAME: | LEVOMILNACIPRAN HYDROCHLORIDE |
SUBSTANCE NAME: | LEVOMILNACIPRAN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-07-25 |
END MARKETING DATE: | 0000-00-00 |
Fetzima HUMAN PRESCRIPTION DRUG Details:
Item Description | Fetzima from Allergan USA, Inc. |
LABELER NAME: | Allergan USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 120(mg/1) |
START MARKETING DATE: | 2013-07-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0456-2212_089df56c-7e5a-48b4-8579-10b9e65ce998 |
PRODUCT NDC: | 0456-2212 |
APPLICATION NUMBER: | NDA204168 |
Other LEVOMILNACIPRAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: